Different mutations in genes such as rpoB, katG, inhA, pncA, embB, rpsL, gyrA, ethA and rrs have been identified as conferring resistance to TB first-line drugs, second-line drugs or injectables, and fluoroquinolones [8,9]. The gene discussed is INHA; the disease is tuberculosis.